Skip to main content
Caplight Logo









CONNEXT

CONNEXT

Private
DaeguEnterprise Softwarehttps://connext.co.kr/

Last Round

Series C

Mar 16, 2026

Total Funding Raised

$21.23M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

CONNEXT is a biotechnology company that develops biological therapeutics, including recombinant TLR5 agonists and recombinant collagenase for fibrotic and orphan diseases.

Sector

Enterprise Software

Verticals

Smart Manufacturing, Enterprise Resource Planning, Data Integration, Workflow Automation, IoT Hardware

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

smart factorymanufacturing execution systemsMESindustrial IoTIIoTsystem integrationfactory automationERPenterprise resource planningdigital transformationproduction monitoringindustry 4.0process automationoperational technologyOT

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

CONNEXT Comparables

Compare CONNEXT with similar companies based on industry and business-model similarity.

CONNEXT comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ariatech Co., Ltd.
83%
ISPark Co., Ltd.
77%
Doople Inc.
76%

CONNEXT Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series CMar 16, 2026
Series BDec 1, 2023
VC RoundApr 16, 2021
Series ANov 1, 2019

Key People

Founding team and executive leadership

Woo Jong Lee

Chief Executive Officer

Executive Team

CONNEXT Investors

Notable investors and investment history

CONNEXT investors
InvestorRounds
KOTECSeries A
KB InvestmentVC Round
The Wells InvestmentSeries A, VC Round
KB InvestmentSeries A, VC Round
Murex PartnersSeries C
Premier PartnersSeries C
ES InvestorSeries C, Series B

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 21, 2026

    Monthly visitors increased 34% MoM.

  • Apr 16, 2021

    $4.48M round led by KB Investment and The Wells Investment.

Recent news

Latest coverage and updates

  • is_developingJul 27, 2026

    CONNEXT Co., Ltd. is developing advanced TLR5 agonist on Jul 27th '26.

CONNEXT Filings

Explore SEC and related filing metadata, where available.

CONNEXT filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about CONNEXT's valuation, stock price, and market status.

Is CONNEXT a public or private company?

CONNEXT is a private company.

What is the current stock price of CONNEXT?

CONNEXT is a private company with no public stock price. No recent secondary market data is available.

How much is CONNEXT worth (valuation)?

Valuation information for CONNEXT is not publicly available.

Can I buy CONNEXT stock?

CONNEXT shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was CONNEXT's last funding round?

CONNEXT's most recent funding round was Series C on March 16, 2026.

Who are the main investors in CONNEXT?

Key investors in CONNEXT include KB Investment, Murex Partners, Premier Partners, ES Investor, LSK Investment.

Will CONNEXT IPO soon?

No public IPO plans have been announced for CONNEXT.

How can I track CONNEXT secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor CONNEXT's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersDaegu
Employee Range3
Year Founded2017
Last FundingMar 16, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?